Neural Network Biopsy Path Correction for Prostate Deformation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current mpMRI-TRUS fusion techniques for prostate cancer biopsy guidance face challenges due to misalignment of biopsy locations over time, leading to suboptimal targeting due to prostate movement and deformation between image registration and biopsy.

Innovation Solution

An ultrasound imaging system utilizing a neural network to identify and spatially delineate cancerous tissue types during a biopsy, generating a tissue distribution map and determining a corrected biopsy path based on real-time ultrasound data, incorporating user input for prioritization and feasibility constraints.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If image registration is performed once at the beginning, then the initial alignment is established, but the prostate movement and deformation between registration and biopsy causes misalignment

Engineering Contradiction:
Improvebiopsy targeting accuracyVSAvoidprostate position stability
Core Design Contradiction:
Measurement precisionVSStability of the object's composition

Solution Approach 1:

The system continuously monitors the prostate's position and deformation during the biopsy procedure and provides real-time feedback to adjust the biopsy path. The neural network analyzes ultrasound images to detect changes in tissue position and updates the target coordinates dynamically, ensuring accurate targeting despite prostate movement between initial registration and biopsy execution.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The biopsy path is transformed from a static pre-planned trajectory to a dynamic adjustable path that adapts to real-time prostate position changes. The system allows continuous modification of the biopsy path based on live ultrasound feedback, enabling the needle to be repositioned to compensate for prostate deformation and maintain precision throughout the procedure.

Inventive Principle:
Principle #15Dynamics

2Ease of operation

If traditional TRUS imaging is used, then real-time imaging is available, but cancerous tissue cannot be distinguished from healthy tissue

Engineering Contradiction:
Improvereal-time imaging capabilityVSAvoidcancerous tissue identification accuracy
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

A neural network serves as an intermediary between the TRUS images and the biopsy targeting decision. The neural network receives real-time ultrasound images, processes them to identify cancerous tissue characteristics, and outputs corrected biopsy path recommendations. This intermediary layer enhances the diagnostic capability of TRUS by automatically detecting cancerous regions that are not visually distinguishable to human operators.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The system changes the parameters used for tissue characterization by applying deep learning models that analyze multiple ultrasound image features simultaneously. The neural network transforms standard TRUS images into enhanced representations that highlight cancerous tissue, effectively changing the detection parameters from simple echo intensity to multi-parameter neural network analysis.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If mpMRI-TRUS fusion is used, then cancerous tissue location is identified, but misalignment occurs due to prostate movement between registration and biopsy

Engineering Contradiction:
Improvecancerous tissue location accuracyVSAvoidbiopsy targeting reliability
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The system incorporates continuous feedback loops that monitor prostate position and deformation during the biopsy procedure. The neural network analyzes real-time ultrasound images to detect deviations from the planned biopsy path and provides feedback to correct the targeting, ensuring reliable biopsy results even when prostate movement occurs between initial mpMRI-TRUS registration and the actual biopsy execution.

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Improves diagnostic precision and treatment decisions by ensuring accurate targeting of specific cancerous tissue grades, reducing the impact of prostate movement and deformation on biopsy accuracy.

Implementation Method 1

an ultrasound transducer configured to transmit ultrasound pulses and detect echo signals responsive to the transmitted pulses

Methodology Applied
Scientific EffectUltrasound: Ultrasound

Data Source

PatentUS20200345325A1Automated path correction during multi-modal fusion targeted biopsy
Publication Date: 2020.11.05 KONINKLIJKE PHILIPS NV
  • US20200345325A1 patent drawing
  • US20200345325A1 patent drawing
  • US20200345325A1 patent drawing

AI summary

The present disclosure describes ultrasound imaging systems and methods configured to delineate sub-regions of bodily tissue within a target region and determine a biopsy path for sampling the tissue. Systems may include an ultrasound transducer configured to image a biopsy plane within a target region. A processor communicating with the transducer can obtain a time series of sequential data frames associated with echo signals acquired by the transducer and apply a neural network to the data frames. The neural network can determine spatial locations and identities of various tissue types in the data frames. A spatial distribution map labeling the coordinates of the tissue types identified within the target region can also be generated and displayed on a user interface. The processor can also receive user input, the neural network determines spatial locations and identities of a plurality of via the user interface, indicating a targeted biopsy sample to be collected, which can be used to determine a corrected biopsy path.